$16.80
-0.27-1.58%
Pre-Market: 4:02 AM EDT
Comments
Loading...
ACADIA Pharmaceuticals Stock Guidance | NASDAQ:ACAD | Benzinga
ACADIA Pharmaceuticals issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 02/26/2025 | ACAD | ACADIA Pharmaceuticals | FY | 2025 | — | — | — | $1.03B | $1.09B | $1.05B | Get Alert |
| 11/06/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $940.00M | $960.00M | $952.48M | Get Alert |
| 08/06/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $930.00M | $980.00M | $953.15M | Get Alert |
| 05/08/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $930.00M | $1.01B | $966.61M | Get Alert |
| 02/27/2024 | ACAD | ACADIA Pharmaceuticals | FY | 2024 | — | — | — | $930.00M | $1.01B | $965.09M | Get Alert |
| 05/08/2023 | ACAD | ACADIA Pharmaceuticals | FY | 2023 | — | — | — | $520.00M | $550.00M | $556.45M | Get Alert |
| 02/27/2023 | ACAD | ACADIA Pharmaceuticals | FY | 2023 | — | — | — | $520.00M | $550.00M | $569.16M | Get Alert |
| 11/02/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $520.00M | $530.69M | Get Alert |
| 08/08/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $540.00M | $531.12M | Get Alert |
| 05/04/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $560.00M | $540.68M | Get Alert |
| 02/28/2022 | ACAD | ACADIA Pharmaceuticals | FY | 2022 | — | — | — | $510.00M | $560.00M | $564.20M | Get Alert |
| 11/08/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $480.00M | $500.00M | $490.42M | Get Alert |
| 08/04/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $480.00M | $515.00M | $521.79M | Get Alert |
| 05/05/2021 | ACAD | ACADIA Pharmaceuticals | FY | 2021 | — | — | — | $510.00M | $550.00M | $535.93M | Get Alert |
| 11/04/2020 | ACAD | ACADIA Pharmaceuticals | FY | 2020 | — | — | — | $430.00M | $450.00M | $443.75M | Get Alert |
| 08/05/2020 | ACAD | ACADIA Pharmaceuticals | FY | 2020 | — | — | — | $430.00M | $450.00M | $437.26M | Get Alert |
FAQ
What is the most recent guidance for ACADIA Pharmaceuticals (ACAD)?
There have been no specific sales or earnings guidance reported for ACADIA Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.